CClinicalTrials.gg
CompletedNCT03650907Updated Aug 13, 2019

Exercise Intervention for Patients With Sarcopenia or Frailty in Long-term Care Institutions

An interventional study of Group exercise program and Self exercise program in Sarcopenia, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 110 Years. Per ClinicalTrials.gov, last updated 2019-08-13.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Non-randomized
Ages
20 Years to 110 Years
Sex
All
01

Study summary

Sarcopenia is a geriatric syndrome of decreased muscle volume with muscular function decline. There is more tendency for sarcopenic elderly to be frail, disabled, or have cardiovascular disease. Compared to those who are not sarcopenic, they also had worse prognosis in response to treatment for definite diseases, and spend more medical cost.

Exercise appears to have an important role in management of sarcopenia. In the current study, the investigators provide an exercise program, including resistance/balance training for the elderly with sarcopenia or frailty in long-term care institution, and evaluate the effect.

02

Conditions studied

  • Sarcopenia
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's enrollment of 52 is below the median of 60 across 775 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. >20-year-old
  2. diagnosed with sarcopenia (by the definition from Asia workgroup for sarcopenia, AWGS) or frailty (The Fried model, based on five functional criteria)

Exclusion criteria

Exclusion Criteria:

  1. Severe medical diseases or mental problems, which result in difficulty to follow exercise program.
  2. Inability to get down from bed for activity due to disease, such as neuropathy or orthopedic disease.
  3. High risk group for exercise program, such as those with unstable fracture or nonunion fracture.
  4. Anyone who didn't want attend this study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Group exercise program by coach

    Behavioral: Group exercise program

  • Sham comparator
    Self exercise

    Behavioral: Self exercise program

Interventions

  • BehavioralGroup exercise program

    Patients in experimental group attend group exercise program, instructed by fitness trainer, at long-term care institutions. Frequency: 3 times per week. Type: resistance/flexibility/balance training, including warm-up and cold-down. Duration: 1 hour per time, for 16 weeks.

  • BehavioralSelf exercise program

    Patients in control group receive oral education for self exercise program, mainly resistance muscle training. Patients are requested to do self-training for 16 weeks.

06

What researchers measure

Primary outcomes

  1. Muscle strength

    grasp strength by dynamometer

    Time frame: after 16-weeks training

  2. walk speed

    6-meter walk test

    Time frame: after 16-weeks training

07

Study locations

1 site
  • Bor-Ay Sweet home
    Keelung, 205, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03650907
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Wen-Chun Tseng (Physiatrist, Physical Medicine and Rehabilitation, Principal Investigator, Chang Gung Memorial Hospital) — Principal investigator
First posted
Aug 29, 2018
Start date
Aug 24, 2018
Primary completion
May 31, 2019
Completion
May 31, 2019
Last update
Aug 13, 2019

Study contacts

Wen-Chun Tseng
principal investigator · Chang Gung Medical Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion